Athira Pharma announced topline results from its Phase 2/3 LIFT-AD clinical trial and reported preliminary cash resources of approximately $75.1 million as of August 31, 2024.
AI Assistant
ATHIRA PHARMA INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.